Over the last 90 days, prior to the date of this filing, there have been 40 insider transactions reported to the SEC for Incyte. These transactions came from the activities of 20 individual insiders that resulted in a net acquisition of 141,621 company shares. In the preceding 90-day window of time, there were 44 transactions from 18 insiders and resulted in the net acquisition of 22,316 shares.
This level of insider transactions is below that of the peer group average in the 207-company Biotechnology & Medical Research peer group over the last 90-day period. Peer group activity averaged 48.8 transactions per company, with company insiders acquiring on average 34,177 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/879169/000120919120023922/xslF345X03/doc4.xml
|Analyst Actions: BofA Securities Downgrades Celanese...|
|Analyst Actions: Guggenheim Downgrades Monro to Neut...|
|Analyst Actions: BofA Securities Upgrades Fox Factor...|
|May Chicago ISM PMI Drops to Lowest Level Since Marc...|
|Analyst Actions: Cowen Downgrades Halliburton Co. to...|